131 related articles for article (PubMed ID: 38084848)
1. Cystoid Macular Edema After Initiation of Ozanimod for Ulcerative Colitis.
Wei L; Patil SA; Cross RK; Taubenslag KJ; Schocket LS
Am J Gastroenterol; 2024 Feb; ():. PubMed ID: 38084848
[No Abstract] [Full Text] [Related]
2. An overview of ozanimod as a therapeutic option for adults with moderate-to-severe active ulcerative colitis.
Rowan C; Ungaro R; Mehandru S; Colombel JF
Expert Opin Pharmacother; 2022 Jun; 23(8):893-904. PubMed ID: 35503955
[TBL] [Abstract][Full Text] [Related]
3. A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis.
Aoun R; Hanauer S
Expert Rev Gastroenterol Hepatol; 2022 May; 16(5):411-423. PubMed ID: 35400292
[TBL] [Abstract][Full Text] [Related]
4. Ozanimod: A Review in Ulcerative Colitis.
Paik J
Drugs; 2022 Aug; 82(12):1303-1313. PubMed ID: 35994200
[TBL] [Abstract][Full Text] [Related]
5. Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.
Choi D; Stewart AP; Bhat S
Ann Pharmacother; 2022 May; 56(5):592-599. PubMed ID: 34423657
[TBL] [Abstract][Full Text] [Related]
6. Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
Cohen NA; Choi D; Garcia N; Choi NK; Picker E; Krugliak Cleveland N; Cohen RD; Dalal SR; Pekow J; Rubin DT
Dig Dis Sci; 2024 Feb; 69(2):579-587. PubMed ID: 38087126
[TBL] [Abstract][Full Text] [Related]
7. Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
Sands BE; Schreiber S; Blumenstein I; Chiorean MV; Ungaro RC; Rubin DT
J Crohns Colitis; 2023 Dec; 17(12):2012-2025. PubMed ID: 37436357
[TBL] [Abstract][Full Text] [Related]
8. Update on ozanimod for ulcerative colitis.
Antonelli EK; Del Sordo R; Morelli O; Villanacci V; Bassotti G
Drugs Today (Barc); 2022 Jul; 58(7):351-367. PubMed ID: 35851870
[TBL] [Abstract][Full Text] [Related]
9. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ; Feagan BG; D'Haens G; Wolf DC; Jovanovic I; Hanauer SB; Ghosh S; Petersen A; Hua SY; Lee JH; Charles L; Chitkara D; Usiskin K; Colombel JF; Laine L; Danese S;
N Engl J Med; 2021 Sep; 385(14):1280-1291. PubMed ID: 34587385
[TBL] [Abstract][Full Text] [Related]
10. Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
Sandborn WJ; Feagan BG; Wolf DC; D'Haens G; Vermeire S; Hanauer SB; Ghosh S; Smith H; Cravets M; Frohna PA; Aranda R; Gujrathi S; Olson A;
N Engl J Med; 2016 May; 374(18):1754-62. PubMed ID: 27144850
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors of Cystoid Macular Edema After Pars Plana Vitrectomy for Pseudophakic Retinal Detachment.
Bernabei F; Marcireau I; Frongia F; Azan F; Vagge A; Peiretti E; Guerrier G; Rothschild PR
Ophthalmol Ther; 2023 Jun; 12(3):1737-1745. PubMed ID: 37029838
[TBL] [Abstract][Full Text] [Related]
12. Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis.
Cohen NA; Dalal SR; Choi D; Rubin DT
ACG Case Rep J; 2022 Jul; 9(7):e00832. PubMed ID: 35919406
[TBL] [Abstract][Full Text] [Related]
13. Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.
Otsubo M; Kinouchi R; Kamiya T; Yoshida A
J Med Case Rep; 2021 Jul; 15(1):355. PubMed ID: 34284818
[TBL] [Abstract][Full Text] [Related]
14. Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature.
Makri OE; Tsapardoni FN; Plotas P; Ifantis N; Xanthopoulou PT; Georgakopoulos CD
BMC Res Notes; 2017 Mar; 10(1):127. PubMed ID: 28320481
[TBL] [Abstract][Full Text] [Related]
15. Cystoid macular edema responds to intravitreal triamcinolone and rebounds after intravitreal bevacizumab.
Sabet-Peyman EJ; Nguyen QD; Do DV
Ophthalmic Surg Lasers Imaging; 2009; 40(4):413-5. PubMed ID: 19634749
[TBL] [Abstract][Full Text] [Related]
16. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes.
Ayyala RS; Cruz DA; Margo CE; Harman LE; Pautler SE; Misch DM; Mines JA; Richards DW
Am J Ophthalmol; 1998 Oct; 126(4):602-4. PubMed ID: 9780112
[TBL] [Abstract][Full Text] [Related]
17. Risperidone-related bilateral cystoid macular edema: a case report.
Kozlova A; McCanna CD; Gelman R
J Med Case Rep; 2019 Mar; 13(1):59. PubMed ID: 30862314
[TBL] [Abstract][Full Text] [Related]
18. Improvement of pseudophakic cystoid macular edema with subconjunctival injections of interferon α2b:a case report.
Aghaei H; Es'haghi A; Pourmatin R
Am J Ophthalmol Case Rep; 2022 Jun; 26():101504. PubMed ID: 35372711
[TBL] [Abstract][Full Text] [Related]
19. Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema.
Maleki A; Aghaei H; Lee S
Am J Ophthalmol Case Rep; 2018 Jun; 10():203-205. PubMed ID: 29560479
[TBL] [Abstract][Full Text] [Related]
20. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost.
Lima MC; Paranhos A; Salim S; Honkanen R; Devgan L; Wand M; Gaudio AR; Shields MB
J Glaucoma; 2000 Aug; 9(4):317-21. PubMed ID: 10958605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
